Norbert Furtmann

Company: Sanofi

Job title: Group Leader & Head of Artificial Intelligence Innovation NANOBODY Platform, Computational & High-throughput Protein Engineering

Bio:

Upon finishing his studies in Pharmaceutical Sciences, Norbert Furtmann pursued his interdisciplinary PhD thesis in Computational Life Sciences and Pharmaceutical Chemistry at the University of Bonn focusing on computer-aided design, synthesis, and biological evaluation of protease inhibitors. After starting his professional career at Merck KGaA as Principal Scientist, Norbert Furtmann joined Sanofi in 2016 as bioinformatician within the Large Molecule Research department where he built a team for Data Science & Computational Design in the past years. Currently Norbert Furtmann is heading the Computational & High-throughput Protein Engineering group to support the discovery of next generation protein therapeutics. In addition, Norbert Furtmann is acting as Head of AI Innovation for Sanofi’s Nanobody platform to develop novel workflows for computational Nanobody design and optimization.

Seminars:

Expanding Predictive Design Beyond Monoclonal Antibodies to Bi- and Multispecific Protein Therapeutics 11:55 am

Discuss challenges within multi-specific protein therapeutic design and discovery, exploring how computational tools can support the optimization tasks   Learn about critical data gaps and strategic data generation approaches specifically tailored for multi-specifics  Examples and case studies demonstrating the application of computational and machine learning models to optimize next-generation multi-specific therapeuticsRead more

day: Conference Day One